Non-melanoma skin cancer: a genetic update and future perspectives

M Zambrano-Román, JR Padilla-Gutiérrez, Y Valle… - Cancers, 2022 - mdpi.com
Simple Summary Non-melanoma skin cancer (NMSC) is the main type of cancer in the
Caucasian population, and the number of cases continues to rise. Research mostly focuses …

The role of teledermatology during the COVID-19 pandemic: a narrative review

A Ruggiero, F Martora, G Fabbrocini… - Clinical, Cosmetic …, 2022 - Taylor & Francis
Teledermatology represented one of the most important and useful tools during the COVID-
19 pandemic era. Indeed, due to the severe restriction, and to reduce the spread of the …

Classification of skin cancer stages using a AHP fuzzy technique within the context of big data healthcare

M Samiei, A Hassani, S Sarspy, IE Komari… - Journal of Cancer …, 2023 - Springer
Background and objectives Skin conditions in humans can be challenging to diagnose. Skin
cancer manifests itself without warning. In the future, these illnesses, which have been an …

The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination

JK Gurney, E Millar, A Dunn, R Pirie… - The Lancet Regional …, 2021 - thelancet.com
Background The COVID-19 pandemic has disrupted cancer services globally. New Zealand
has pursued an elimination strategy to COVID-19, reducing (but not eliminating) this …

The epidemiology of malignant melanoma during the first two years of the COVID-19 pandemic: a systematic review

AO Toma, M Prodan, AR Reddyreddy… - International Journal of …, 2022 - mdpi.com
It is hypothesized that the COVID-19 pandemic had a major impact on the epidemiology of
malignant melanoma owing to diminished screening, diagnostic, and treatment capacities …

Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital

M Valenti, G Pavia, L Gargiulo… - International journal …, 2021 - Wiley Online Library
Background The COVID‐19 pandemic required the setting of a national lockdown in Italy
from March 9, 2020, until May 18, 2020; therefore, most of the non‐COVID‐19 activities were …

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a scoping review

AS Carvalho, Ó Brito Fernandes, M de Lange… - BMC health services …, 2022 - Springer
Background Cancer comprises a high burden on health systems. Performance indicators
monitoring cancer outcomes are routinely used in OECD countries. However, the …

[HTML][HTML] Cancer diagnosis in Catalonia (Spain) after two years of COVID-19 pandemic: an incomplete recovery

J Ribes, L Pareja, X Sanz, S Mosteiro, JM Escribà… - ESMO open, 2022 - Elsevier
Background This study aimed to estimate potential undetected cancers over the first 2 years
of the COVID-19 pandemic in Catalonia. Methods Cancer incidence was compared between …

The impact of the COVID‐19 pandemic on cancer diagnosis based on pathology notifications: a comparison across the Nordic countries during 2020

ALV Johansson, S Larønningen… - … journal of cancer, 2022 - Wiley Online Library
The severity of the COVID‐19 pandemic and subsequent mitigation strategies have varied
across the Nordic countries. In a joint Nordic population‐based effort, we compared patterns …

Effects of COVID-19 lockdown on melanoma diagnosis in Switzerland: increased tumor thickness in elderly females and shift towards stage IV melanoma during …

L Kostner, SE Cerminara, GSP Pamplona, JT Maul… - Cancers, 2022 - mdpi.com
Simple Summary Concerns about potential diagnostic delays due to pandemic-related
disruptions were expressed early during the COVID-19 outbreak. In the present study, we …